NeuroLutions
CA - Van NuysBiotechnology
Focus: NeuroLutions is a publicly traded biotech company developing the IpsiHand System, a brain-computer interface (BCI) device for stroke recovery and chronic stroke rehabilitation. The company focuses on neurorehabilitation in the neurology/cardiovascular space with a single-product platform.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About NeuroLutions
AI assessmentNot HiringNo open roles listed right now. Follow NeuroLutions to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
IpsiHand System
Growth
Flagship BCI-driven rehabilitation device; represents entire commercial strategy and pipeline (5 trials, all variations of same platform).
Pipeline & Clinical Trials
IpsiHand Treatment
StrokeHelp build intelligence for NeuroLutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.